Fig. 4: Impact of disease stage on relapse free-survival (RFS).

Advanced disease stage (defined as other than CP1) at start of 2GTKI treatment (a) and at time of allo-HCT (b) had a negative impact on RFS.

Advanced disease stage (defined as other than CP1) at start of 2GTKI treatment (a) and at time of allo-HCT (b) had a negative impact on RFS.